Pediatrix Medical Group, Inc. (NYSE:MD) Receives $9.38 Consensus Target Price from Brokerages

Shares of Pediatrix Medical Group, Inc. (NYSE:MD) have been assigned a consensus recommendation of “Hold” from the four analysts that are presently covering the firm, Marketbeat.com reports. Four investment analysts have rated the stock with a hold recommendation. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $9.38.

Several equities analysts recently issued reports on MD shares. Mizuho dropped their price target on Pediatrix Medical Group from $10.00 to $9.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 21st. TheStreet cut Pediatrix Medical Group from a “c” rating to a “d” rating in a research report on Friday, February 23rd. Jefferies Financial Group lowered their price objective on Pediatrix Medical Group from $10.00 to $9.00 and set a “hold” rating on the stock in a report on Wednesday, March 6th. Finally, Truist Financial reaffirmed a “hold” rating and issued a $10.00 price objective on shares of Pediatrix Medical Group in a report on Wednesday, May 15th.

Pediatrix Medical Group Stock Performance

Shares of MD stock opened at $7.46 on Monday. The stock’s 50-day moving average is $8.95 and its two-hundred day moving average is $9.12. The firm has a market cap of $627.76 million, a price-to-earnings ratio of -8.78, a PEG ratio of 1.42 and a beta of 1.58. Pediatrix Medical Group has a 1 year low of $7.26 and a 1 year high of $15.02. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.72 and a current ratio of 1.72.

Pediatrix Medical Group (NYSE:MD) last issued its quarterly earnings results on Tuesday, May 7th. The company reported $0.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.15 by $0.02. The firm had revenue of $495.10 million for the quarter, compared to analysts’ expectations of $496.25 million. Pediatrix Medical Group had a positive return on equity of 10.31% and a negative net margin of 3.53%. Analysts predict that Pediatrix Medical Group will post 1.12 earnings per share for the current year.

Institutional Investors Weigh In On Pediatrix Medical Group

Institutional investors have recently modified their holdings of the company. Performa Ltd US LLC boosted its stake in shares of Pediatrix Medical Group by 130.8% during the 4th quarter. Performa Ltd US LLC now owns 3,000 shares of the company’s stock worth $28,000 after acquiring an additional 1,700 shares in the last quarter. Counterpoint Mutual Funds LLC boosted its stake in shares of Pediatrix Medical Group by 53.4% during the 4th quarter. Counterpoint Mutual Funds LLC now owns 10,140 shares of the company’s stock worth $94,000 after acquiring an additional 3,528 shares in the last quarter. AXQ Capital LP purchased a new stake in shares of Pediatrix Medical Group during the 3rd quarter worth approximately $135,000. Virtu Financial LLC purchased a new stake in shares of Pediatrix Medical Group during the 1st quarter worth approximately $124,000. Finally, TD Asset Management Inc purchased a new stake in shares of Pediatrix Medical Group during the 3rd quarter worth approximately $167,000. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.